首页> 外文期刊>Behavioural Brain Research: An International Journal >Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors.
【24h】

Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors.

机译:苯环利定诱导的歧视性刺激是通过N-甲基-D-天冬氨酸受体-离子通道复合物上的苯环利定结合位点而不是通过sigma(1)受体介导的。

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of several N-methyl-D-aspartate (NMDA) receptor- and sigma receptor-related compounds on the discriminative stimulus effects of phencyclidine (PCP) were examined in rats trained to discriminate PCP (1.5 mg/kg, i.p.) from saline under a two-lever fixed ratio 20 schedule of food reinforcement. PCP produced a dose-dependent increase in PCP-appropriate responding. A non-competitive NMDA receptor antagonist, dizocilpine (0.2 mg/kg, i.p.) and a putative sigma(1) receptor agonist, (+)-SKF-10047 (10 mg/kg, i.p.) fully substituted for PCP in every rat tested. Neither a competitive NMDA receptor antagonist, CGS-19755 (0.1-3 mg/kg, i.p.), sigma(1) receptor agonist, (+)-pentazocine (10-30 mg/kg, i.p.) nor dextromethorphan (10-20 mg/kg, i.p.) produced PCP-like discriminative stimulus effects. The discriminative stimulus effects of PCP (1.5 mg/kg, i.p.), dizocilpine (0.2 mg/kg, i.p.) and (+)-SKF-10047 (10 mg/kg, i.p.) were significantly attenuated by CGS-19755 (1 mg/kg, i.p.), but not by sigma(1) receptor antagonist BMY-14802 (10 mg/kg, i.p.) and NE-100 (5 mg/kg, i.p.). These results suggest that the discriminative stimulus effects of PCP are predominantly mediated via PCP binding sites on the NMDA receptor-ion channel complex, not via sigma(1) receptors. In addition, the PCP-like discriminative stimulus effects of (+)-SKF-10047 were demonstrated to be mediated via PCP binding sites.
机译:在训练中从盐水中区分PCP(1.5 mg / kg,ip)的大鼠中,研究了几种N-甲基-D-天冬氨酸(NMDA)受体和sigma受体相关化合物对苯环利定(PCP)的歧视性刺激作用的影响。在两杆固定比例的20个食物强化时间表下。 PCP在PCP适当的响应中产生剂量依赖性的增加。非竞争性NMDA受体拮抗剂地佐西平(0.2 mg / kg,ip)和推定的sigma(1)受体激动剂(+)-SKF-10047(10 mg / kg,ip)在每只接受试验的大鼠中均完全替代PCP 。竞争性NMDA受体拮抗剂,CGS-19755(0.1-3 mg / kg,腹膜内),sigma(1)受体激动剂,(+)-喷他佐辛(10-30 mg / kg,腹膜内)或右美沙芬(10-20 mg) / kg,ip)产生了PCP样的歧视性刺激效果。 CGS-19755(1 mg)显着减弱了五氯苯酚(1.5 mg / kg,ip),地佐西平(0.2 mg / kg,ip)和(+)-SKF-10047(10 mg / kg,ip)的歧视性刺激作用。 / kg,ip),但不接受sigma(1)受体拮抗剂BMY-14802(10 mg / kg,ip)和NE-100(5 mg / kg,ip)。这些结果表明,PCP的歧视性刺激作用主要是通过NMDA受体离子通道复合体上的PCP结合位点而不是通过sigma(1)受体介导的。此外,已证明(+)-SKF-10047的PCP样歧视性刺激作用是通过PCP结合位点介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号